Mereo Biopharma Group PL-ADRMREO
13F holders, Q1 2024 (March 31)80holders
5famous investors
$3.30avg. 13F price*
At the end of Q1 2024, 80 institutions reported holding Mereo Biopharma Group PL-ADR (MREO) in their 13F filings. The largest holders were Rubric Capital Management LP ($44.7M), Adage Capital Partners Gp, L.L.C. ($30.8M) and Mangrove Partners Im, LLC ($28.9M). 5 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
- Company
- Mereo Biopharma Group PL-ADR
- CUSIP
- 589492107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 28 | $30.9M |
| Exits | 11 | $3.0M |
Ownership 80 holders
| Rubric Capital Management LP | 1.32% | No change | 13,552,997 | $44.7M |
| Adage Capital Partners Gp, L.L.C. | 0.06% | Add +252.0% | 9,328,739 | $30.8M |
| Mangrove Partners Im, LLC | 2.48% | No change | 8,752,893 | $28.9M |
| Rock Springs Capital Management LP | 0.68% | Add +2.0% | 8,142,109 | $26.9M |
| 683 Capital Management, LLC | 2.09% | Reduce -7.3% | 5,750,000 | $19.0M |
| Janus Henderson Group PLC | 0.01% | New | 5,120,573 | $16.9M |
| Alkeon Capital Management LLC | 0.08% | No change | 4,238,100 | $14.0M |
| Montanova Capital, LLC | 0.51% | Reduce -50.4% | 3,653,494 | $12.1M |
| Clearline Capital LP | 1.08% | No change | 3,326,718 | $11.0M |
| Soleus Capital Management, L.P. | 0.76% | Reduce -73.2% | 2,616,953 | $8.6M |
| Tejara Capital Ltd | 3.02% | Reduce -33.5% | 2,470,184 | $8.2M |
| Goldman Sachs Group Inc. | 0.00% | Add +10.9% | 2,243,814 | $7.4M |
| Millennium Management | 0.01% | Add +54.5% | 2,179,135 | $7.2M |
| Renaissance Technologies | 0.01% | Reduce -7.0% | 1,672,309 | $5.5M |
| Susquehanna International Group, LLP | 0.01% | Add +822.2% | 1,619,627 | $5.3M |
| Morgan Stanley | 0.00% | Add +1715.4% | 1,382,689 | $4.6M |
| T. Rowe Price Associates Inc. | 0.00% | New | 991,971 | $3.3M |
| Integral Health Asset Management, LLC | 0.31% | New | 950,000 | $3.1M |
| Aberdeen Group plc | 0.01% | Reduce -47.3% | 817,309 | $2.7M |
| NEOS Investment Management LLC | 0.13% | Add +77.2% | 623,430 | $2.1M |
| Verition Fund Management LLC | 0.02% | New | 485,436 | $1.6M |
| Artia Global Partners LP | 0.34% | New | 421,359 | $1.4M |
| Monaco Asset Management SAM | 0.59% | Reduce -40.1% | 405,000 | $1.3M |
| Acuta Capital Partners, LLC | 0.85% | New | 397,884 | $1.3M |
| Two Sigma Investments, LP | 0.00% | Add +13.1% | 351,729 | $1.2M |
| J. Goldman & Co LP | 0.04% | Add +72.0% | 278,588 | $919K |
| Knoll Capital Management, LLC | 0.53% | Add +62.3% | 260,470 | $860K |
| Global IMC LLC | 0.15% | New | 195,087 | $644K |
| Fred Alger Management, LLC | 0.00% | Add +90.1% | 194,879 | $643K |
| TD Asset Management Inc | 0.00% | New | 148,000 | $488K |
| Jump Financial, LLC | 0.01% | New | 126,500 | $417K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 118,978 | $393K |
| Qube Research & Technologies Ltd | 0.00% | Add +239.9% | 109,327 | $361K |
| Geode Capital Management, LLC | 0.00% | No change | 96,630 | $319K |
| Jane Street Group, LLC | 0.00% | New | 86,873 | $287K |
| Bank of America Corp. | 0.00% | Add +28421.0% | 78,718 | $260K |
| Gsa Capital Partners LLP | 0.02% | New | 75,787 | $250K |
| Envestnet Asset Management Inc. | 0.00% | Add +18.5% | 55,903 | $184K |
| Primecap Management Co. | 0.00% | No change | 54,000 | $178K |
| Squarepoint Ops LLC | 0.00% | New | 47,687 | $157K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +220.2% | 47,030 | $155K |
| Clear Harbor Asset Management, LLC | 0.01% | Reduce -23.0% | 46,000 | $152K |
| Citadel Advisors | 0.00% | Reduce -86.5% | 43,907 | $145K |
| Forefront Analytics, LLC | 0.07% | Add +21.3% | 43,817 | $145K |
| JPMorgan Chase & Co. | 0.00% | Add +99.4% | 38,122 | $126K |
| BlackRock Inc. | 0.00% | Add +453.7% | 32,843 | $108K |
| PFG Investments, LLC | 0.01% | Add +4.0% | 31,200 | $103K |
| Knott David M Jr | 0.04% | New | 30,000 | $99K |
| Index Fund Advisors, Inc. | 0.01% | New | 30,000 | $99K |
| Simplex Trading, LLC | 0.00% | New | 29,242 | $96K |
| HSBC Holdings PLC | 0.00% | Reduce -50.9% | 28,577 | $94K |
| Tudor Investment Corporation | 0.00% | New | 26,179 | $86K |
| Centiva Capital, LP | 0.01% | No change | 25,000 | $83K |
| OneDigital Investment Advisors LLC | 0.00% | Reduce -2.1% | 18,513 | $61K |
| BNP Paribas Financial Markets | 0.00% | Add +581066.7% | 17,435 | $58K |
| SG Americas Securities, LLC | 0.00% | New | 16,221 | $54K |
| GTS Securities LLC | 0.00% | New | 15,664 | $52K |
| Level Four Advisory Services, LLC | 0.00% | No change | 20,000 | $46K |
| Total Clarity Wealth Management, Inc. | 0.01% | New | 11,860 | $39K |
| NFSG Corp | 0.02% | Add +23.2% | 11,700 | $39K |
| Advisors Preferred, LLC | 0.00% | New | 8,262 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,145 | $24K |
| GAMMA Investing LLC | 0.00% | Add +29.8% | 5,987 | $20K |
| Rhumbline Advisers | 0.00% | Add +4.1% | 4,071 | $13K |
| Arax Advisory Partners | 0.00% | No change | 4,000 | $13K |
| Lindbrook Capital, LLC | 0.00% | New | 2,300 | $8K |
| Point72 Asset Management | 0.00% | New | 1,900 | $6K |
| Allworth Financial LP | 0.00% | No change | 1,500 | $5K |
| ICA Group Wealth Management, LLC | 0.00% | New | 1,000 | $3K |
| Bfsg, LLC | 0.00% | New | 1,000 | $3K |
| Sit Investment Associates Inc. | 0.00% | No change | 970 | $3K |
| Signaturefd, LLC | 0.00% | New | 820 | $3K |
| Quadrant Capital Group LLC | 0.00% | New | 739 | $2K |
| US Bancorp \de | 0.00% | Add +3076.9% | 413 | $1K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 300 | $990 |
| Wells Fargo & Company | 0.00% | No change | 230 | $757 |
| Highlander Capital Management, LLC | 0.00% | No change | 127 | $419 |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 48 | $158 |
| Barclays PLC | 0.00% | No change | 38 | $125 |
| Royal Bank of Canada | 0.00% | Reduce -50.9% | 28 | $0 |
"% of holder's portfolio" is MREO's weight in each manager's 13F, not the share of Mereo Biopharma Group PL-ADR the manager owns.